Management of pharyngolaryngeal dysesthesia associated with oxaliplatin therapy.
Barhamand
Barbara
B
Hematology Oncology Consultants, Naperville, IL, USA. BBarhamand@yahoo.com
D000927:Anticonvulsants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002220:Carbamazepine / Q000627:therapeutic use*; D006801:Humans; D007830:Larynx; D009729:Nursing / Q000379:methods*; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin; D010292:Paresthesia / Q000139:chemically induced* / Q000188:drug therapy*; D010353:Patient Education as Topic; D010614:Pharynx
D000927:Anticonvulsants; D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002220:Carbamazepine